Photo of Hope Rugo from ucsfhealth.org
May 18, 2024, 08:47
Elisa Agostinetto: At ESMO Breast24, Hope Rugo presents results of CAPItello-291
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on X/Twitter:
”At ESMO Breast24, Hope Rugo presents results of CAPItello-291: Capivasertib + fulvestrant in aromatase inhibitor-resistant HR+/HER2 – ABC showed significant increase in:
- PFS2.
- Time to subsequent CT.
Improvements both in the overall and PIK3CA/AKT1/PTEN altered populations.”
Source: Elisa Agostinetto/X
